ProQR Therapeutics (PRQR) Times Interest Earned (2013 - 2026)
ProQR Therapeutics (PRQR) posted Times Interest Earned of -$290.4 for Q1 2026, down 5323.73% sequentially from -$5.35 in Q4 2025, and down 463.84% YoY from $79.82 in Q1 2025.
Powered by 
Analysis
ProQR Therapeutics (PRQR) Times Interest Earned (2013 - 2026) Analysis & Trends
ProQR Therapeutics has reported Times Interest Earned for 12 years, with the latest figure at -$290.4 in Q1 2026.
- Quarterly Times Interest Earned fell 463.84% year-over-year to -$290.4 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$28.0 (down 55.35% YoY) and the FY2025 annual result came in at -$33.76, down 20.09% from the prior year.
- Times Interest Earned eased to -$290.4 in Q1 2026 per PRQR's latest filing, from -$5.35 in the prior quarter.
- Over five years, Times Interest Earned peaked at $74.73 in Q3 2025 and troughed at -$290.4 in Q1 2026.
- A 4-year average of -$33.48 and a median of -$5.35 in 2025 frame the typical range for Times Interest Earned.
- The widest YoY moves for Times Interest Earned: up 87.76% in 2025, down 1143.22% in 2025.
- Over 4 years, Times Interest Earned stood at -$1.71 in 2022, then sank by 252.9% to -$6.02 in 2024, then climbed by 11.04% to -$5.35 in 2025, then sank by 5323.73% to -$290.4 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$290.4, -$5.35, and $74.73 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | ProQR Therapeutics | 218.57 Mn | 82.18 Mn | - | -41.61 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -41.61 |
| Dec 31, 2025 | 4.11 |
| Sep 30, 2025 | -40.30 |
| Jun 30, 2025 | -63.80 |
| Mar 31, 2025 | -23.77 |
| Dec 31, 2024 | 3.95 |
| Sep 30, 2024 | -18.58 |
| Jun 30, 2024 | -7.02 |
| Mar 31, 2024 | -16.55 |
| Dec 31, 2023 | 3.59 |
| Sep 30, 2023 | -20.36 |
| Jun 30, 2023 | -18.75 |
| Mar 31, 2023 | 17.26 |
| Dec 31, 2022 | 2.05 |
| Sep 30, 2022 | -33.09 |
| Jun 30, 2022 | -13.61 |
| Mar 31, 2022 | 20.73 |
| Dec 31, 2021 | 58.15 |
| Sep 30, 2021 | -54.73 |
| Jun 30, 2021 | 5.36 |